DOWNLOAD A PDF OF THIS REPORT pdf(0.1MB)
Contact
Shaun BismanPartner [email protected] 212-921-9365 Theo Allen
Associate [email protected] 646-568-1157
With the 2021 proxy season already underway, our understanding of ISS’ tolerance for COVID-related compensation changes is becoming clearer, as ISS has begun to release their proxy research reports ahead of the annual meetings for companies with fall fiscal year-ends. For calendar year-end filers, these reports will serve as weathervanes for ISS’ reaction to incentive plan changes made in response to the pandemic.
To provide insight into the proxy advisor’s disposition this year, CAP reviewed select broad market COVID-19 executive compensation actions and the corresponding ISS report commentary. Our analysis highlights six companies that made various changes to their annual and long-term incentive plans and awarded one-time special grants.
CAP’s preliminary findings indicate that if a company made COVID-related compensation changes and received an elevated level of concern on the ISS pay for performance evaluation, the proxy advisor will likely recommend Against the Say on Pay proposal, thereby significantly impacting the Say on Pay vote. To date, we have observed four companies that experienced sharp declines in their Say on Pay results, with two failing to receive majority support.
Impact of ISS’ Quantitative Pay for Performance Evaluation on Say on Pay Recommendations
Based on our early read, it appears that ISS’ assessment of pay decisions related to COVID-19 is highly correlated to the concern level on their quantitative CEO pay for performance screens, which inform Say on Pay recommendations. When there is a low concern level, a company’s COVID-related changes seem to be more palatable for ISS; however, when there is an elevated level of concern, ISS seems likely to delve more deeply into a compensation program and view any COVID-related changes more critically.
True to the sentiments expressed in their October 2020 Frequently Asked Questions (FAQs), ISS seems highly skeptical of one-time special awards and discretionary upward adjustments to annual and long-term incentive payouts (especially if payouts were tracking well below target). Four of the companies we analyzed were chided for making discretionary incentive plan changes, such as altering performance periods to exclude the months most heavily affected by the pandemic and trigger payouts despite COVID impacts. ISS also found special grants problematic, particularly when used to replace underperforming performance-based awards.
Conversely, two companies made COVID-related compensation changes that seemed more acceptable from ISS’ perspective and in-line with their FAQs. These changes included adjustments to the threshold and target performance goals for in-flight long-term incentives, bifurcated performance periods with payouts well below target for annual incentive awards, and modest special one-time grants.
Supplemental Filings
Supplemental filings from two companies, Aramark and Becton, Dickinson, indicate their frustration with the proxy advisor’s inflexibility considering the unprecedented events of the past year. One company urged that its actions be viewed within the “broader context of executive compensation,” while the other went so far as to suggest that ISS did not have the “resources or business experience to understand” the complexities of its business.
Summary of Executive Compensation Actions and Say on Pay Results
The table below summarizes the actions of six companies that made changes to their incentive plans and provides results from their votes on Say on Pay. Thus far, four companies passed and two failed to receive majority support on their Say on Pay votes.
Company |
Total Shareholder Return (TSR) as of FYE |
Actions |
Say on Pay Results (% Support) |
Walgreens Boots Alliance, Inc. Industry Group: Food and Staples Retailing FY Ended: 8/31/2020 |
1-Yr: 3-Yr CAGR: |
Adjusted AI Payout / Performance Period:
Changed Go-Forward AI Metrics:
LTI Award Modification (2018-2020):
Changed Go-Forward LTI Plan:
|
2021: 47% 2020: 83% |
Becton, Dickinson and Company Industry Group: Health Care Equip. and Svcs. FY Ended: 9/30/2020 Issued a supplemental filing providing additional context regarding the special, one-time grant |
1-Yr: 3-Yr CAGR: |
Adjusted AI Payout / Performance Period:
Special LTI Grant:
|
2021: 67% 2020: 89% |
Aramark Industry Group: Consumer Services FY Ended: 10/2/2020 Issued a supplemental filing on 1/22/2021 providing additional context regarding the LTI award modification and adjusted AI payout |
1-Yr: 3-Yr CAGR: |
Adjusted AI Payout / Performance Period:
Changed Go-Forward AI Metrics:
LTI Award Modification (2018-2020):
Changed Go-Forward LTI Plan:
Special LTI Grant:
Changed Grant Schedule for 2021 LTI:
|
2021: 57% 2020: 93% |
Meritor, Inc. Industry Group: Capital Goods FY Ended: 9/30/2020 |
1-Yr: 3-Yr CAGR: |
Adjusted AI Payout / Performance Period:
LTI Award Modification (2019-2021):
|
2021: 99% 2020: 99% |
PTC Inc. Industry Group: Software and Services FY Ended: 9/30/2020 |
1-Yr: 3-Yr CAGR: |
Adjusted AI Payout / Performance Period:
LTI Award Modification (2018-2020, 2019-2021, 2020-2022):Performance Share Units (PSUs) are measured on an annual basis over three years
|
2021: 49% 2020: 67% |
Digi International Industry Group: Technology Hardware and Equipment FY Ended: 9/30/2020 |
1-Yr: 3-Yr CAGR: |
Adjusted AI Payout / Performance Period:
Special LTI Grant:
|
2021: 97% 2020: 99% |
CAGR = Compound Annual Growth Rate
As calendar year-end companies confirm 2020 payouts, design 2021 incentive plans, and finalize their Compensation Discussion and Analysis (CD&A) in the proxy statement, beware that ISS is highly critical of special one-time awards, upward (discretionary) adjustments to payouts, front loading annual equity awards, and reductions in performance-based long-term incentives. It will be imperative that companies have compelling rationales as to why these decisions were made and how they are aligned with long-term shareholder value creation. As proxies continue to be filed and companies disclose more COVID-related changes, we should have a better sense of proxy advisory firms’ receptiveness to such alterations.
If an early read is any indication, numerous COVID-related compensation changes and negative one-year TSR can affect a company’s Say on Pay vote. As evidenced by the adjustments at Aramark, Becton, Dickinson, PTC and Walgreens Boots Alliance, there was a significant drop in their Say on Pay votes in 2021, with shareholders objecting to compensation changes. Since Say on Pay went into effect in 2011, median support was 95 percent plus, but 10 years later, we may expect to see that median level of support decrease.
This article highlights ISS’ commentary on broad market COVID-19 executive compensation actions. For more detail regarding companies’ COVID-related changes, please visit our COVID-19 Resource Center.